Pharma Reviews: Pharma sector: Earnings downgrade is yet to bottom out

A large chunk of incremental investments by Indian pharmaceutical companies have been in complex and specialty. The sector's R&D spends have ...
Read more: Pharma sector: Earnings downgrade is yet to bottom out